Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


9th Public Relations & Communications Summit

16 Jul 2013 - 17 Jul 2013 - Boston, MA, USA



Bookmark and Share


Out of the Box Keynotes. New Location. Un-conference discussion intensive sessions. The Senior Leadership Forum. Patient perspectives.

What Can You Expect from the 9th PR & Communications Summit?

The Senior Leadership Forum: A dedicated forum for senior directors or higher to discuss outside-of-communications topics in a 100% discussion-based format.

New Perspectives: We did extensive research and found the highest caliber of professionals working on key projects now to share their invaluable insights.

New Location: Boston, in addition to its growing pharma heavy presence, provides new faces and a new city to use as the backdrop to the event, which includes a tour of the MIT research facility.

Customizable Networking and Down Time: Whether meditation is your bag or speed networking and a tour of a research facility is what you want, you have options at this year’s event to maximize your time and monetary investment to your specifications.

Brand New Topics: Patient perspectives, Healthcare Reform interview, Innovation in Healthcare discussions- on top of the PR and communications discussions you need, we’re including more healthcare related topics to help you do your job better.



Further information
Scientific News
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Recruitment of First Patient in Clinical Study
Company has announced recruitment of first patient in clinical study assessing Visco-ease with Beatson Cancer Centre for the treatment of RIX.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Chi-Med Initiates Sulfatinib Phase III Registration Study
Company has initiated SANET-p, a Phase III registration trial of sulfatinib with pancreatic neuroendocrine tumors (“NETs”).
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!